Search Page

1

Recent advances in inhibitors of sirtuin1/2: an update and perspective.

Zhou Z, Ma T, Zhu Q, Xu Y, Zha X. Zhou Z, et al. Among authors: Zha X. Future Med Chem. 2018 Apr 1;10(8):907-934. doi: 10.4155/fmc-2017-0207. Epub 2018 Apr 12. Future Med Chem. 2018. PMID: 29642711 Review.

Cite

Share

2

Novel Opioid Receptor Agonists with Reduced Morphine-like Side Effects.

Zhu L, Cui Z, Zhu Q, Zha X, Xu Y. Zhu L, et al. Among authors: Zha X. Mini Rev Med Chem. 2018;18(19):1603-1610. doi: 10.2174/1389557518666180716124336. Mini Rev Med Chem. 2018. PMID: 30009707 Review.

Cite

Share

3

Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.

Ge Y, Yang G, Wang N, Zha X, Yu X, Mao H, Sun B, Zeng M, Zhang B, Xing C. Ge Y, et al. Among authors: Zha X. Int Urol Nephrol. 2019 Aug;51(8):1443-1449. doi: 10.1007/s11255-019-02217-y. Epub 2019 Jul 1. Int Urol Nephrol. 2019. PMID: 31264087

Cite

Share

4

Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer.

Xie F, Chen R, Zhang L, Yin Z, Zhu Q, You S, Jiang C, Li Y, Li S, Zha X, Wang J. Xie F, et al. Among authors: Zha X. Nanomedicine (Lond). 2019 Jun;14(12):1595-1603. doi: 10.2217/nnm-2018-0485. Epub 2019 Apr 12. Nanomedicine (Lond). 2019. PMID: 30977429

Cite

Share

5

I-8, a novel inhibitor of mutant IDH1, inhibits cancer progression in vitro and in vivo.

Jia P, Wu Y, Du H, Yang L, Zhang Z, Ma T, Li S, Yuan S, Lu L, Zha X. Jia P, et al. Among authors: Zha X. Eur J Pharm Sci. 2019 Dec 1;140:105072. doi: 10.1016/j.ejps.2019.105072. Epub 2019 Sep 10. Eur J Pharm Sci. 2019. PMID: 31518680

Cite

Share

6

^99mTc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism.

Zeng M, Liu W, Zha X, Tang S, Liu J, Yang G, Mao H, Yu X, Sun B, Zhang B, Ouyang C, Zhang L, Guo J, Wang J, Huang Y, Purrunsing Y, Qian H, Wang N, Xing C. Zeng M, et al. Among authors: Zha X. Ren Fail. 2019 Nov;41(1):885-892. doi: 10.1080/0886022X.2019.1662804. Ren Fail. 2019. PMID: 31537128 Free PMC article.

Cite

Share

7

Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease.

Huimin C, Ying C, Changying X, Xiaoming Z, Yan Z, Qingting W, Haoyang M, Lina Z, Ming Z, Guang Y, Xiaolin L, Purrunsing Y, Ningning W. Huimin C, et al. Among authors: Xiaoming Z. Horm Metab Res. 2018 Oct;50(10):761-767. doi: 10.1055/a-0723-2807. Epub 2018 Sep 17. Horm Metab Res. 2018. PMID: 30223287

Cite

Share

8

Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective.

Ma T, Zou F, Pusch S, Xu Y, von Deimling A, Zha X. Ma T, et al. Among authors: Zha X. J Med Chem. 2018 Oct 25;61(20):8981-9003. doi: 10.1021/acs.jmedchem.8b00159. Epub 2018 Jun 18. J Med Chem. 2018. PMID: 29847930 Review.

Cite

Share

9

AMP-activated protein kinase and energy balance in breast cancer.

Zhao H, Orhan YC, Zha X, Esencan E, Chatterton RT, Bulun SE. Zhao H, et al. Among authors: Zha X. Am J Transl Res. 2017 Feb 15;9(2):197-213. eCollection 2017. Am J Transl Res. 2017. PMID: 28337254 Free PMC article. Review.

Cite

Share

10

Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.

Xi J, Xu S, Zhang L, Bi X, Ren Y, Liu YC, Gu Y, Xu Y, Lan F, Zha X. Xi J, et al. Among authors: Zha X. Bioorg Chem. 2018 Aug;78:7-16. doi: 10.1016/j.bioorg.2018.02.016. Epub 2018 Feb 16. Bioorg Chem. 2018. PMID: 29524666

Cite

Share